These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9046995)

  • 1. Diurnal variation in plasma homovanillic acid: not a renal phenomenon.
    Stroe AE; Amin F; Hashmi A; Densmore D; Kahn T; Knott PJ
    Biol Psychiatry; 1997 Mar; 41(5):621-3. PubMed ID: 9046995
    [No Abstract]   [Full Text] [Related]  

  • 2. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E; Bollini AM; Sanfilipo M; Wieland S; Angrist B; Cooper TB; Rotrosen J
    Schizophr Res; 2006 Jan; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of renal factors in plasma homovanillic acid measurements.
    Amin F; Stroe AE; Kahn T; Knott PJ; Kahn RS; Davidson M
    Neuropsychopharmacology; 1998 Apr; 18(4):317-20. PubMed ID: 9509499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects.
    Posener JA; Schildkraut JJ; Samson JA; Schatzberg AF
    Psychoneuroendocrinology; 1996 Jan; 21(1):33-8. PubMed ID: 8778902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variations in plasma monoamine metabolites level in alcoholic patients: a possible predictor of alcohol withdrawal delirium.
    Sano H; Suzuki Y; Ohara K; Miyasato K; Yokoyama T; Ohara K
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):741-52. PubMed ID: 7524113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acid.
    Wright-Honari S; Marshall EF; Ashton CH; Hassanyeh F
    Biomed Chromatogr; 1990 Sep; 4(5):201-4. PubMed ID: 1703800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ceruletide on plasma monoamine metabolites in the rabbit.
    Wakata N; Kawamura Y; Kobayashi M; Sumiyoshi S; Okada K; Kinoshita M
    J Neurol Sci; 1991 May; 103(1):97-100. PubMed ID: 1713954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects.
    Sano H; Suzuki Y; Yazaki R; Tamefusa K; Ohara K; Yokoyama T; Miyasato K; Ohara K
    Acta Psychiatr Scand; 1993 Apr; 87(4):291-6. PubMed ID: 7683838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and reliable high-performance liquid chromatographic method for analysing human plasma serotonin, 5-hydroxyindoleacetic acid, homovanillic acid and 3,4-dihydroxyphenylacetic acid.
    Cheng FC; Kuo JS; Chang WH; Juang DJ; Shih Y; Lai JS
    J Chromatogr; 1993 Aug; 617(2):227-32. PubMed ID: 7691858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions.
    Sack DA; James SP; Doran AR; Sherer MA; Linnoila M; Wehr TA
    Arch Gen Psychiatry; 1988 Feb; 45(2):162-6. PubMed ID: 3337614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on plasma levels of homovanillic acid (phVA) under influence of mental stress.
    Oranje B; Bijl S; Campagne A; Gispen-de Wied CC
    Neuropsychopharmacology; 2000 Sep; 23(3):345-6. PubMed ID: 11032428
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
    Mitani H; Shirayama Y; Yamada T; Kawahara R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia and plasma homovanillic acid in response to mental stress: methodological considerations.
    Sumiyoshi T; Kurachi M; Itoh H
    Neuropsychopharmacology; 2000 Sep; 23(3):347-9. PubMed ID: 11032429
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.
    Fukuda M; Niwa S; Hiramatsu K; Hata A; Nakagome K; Iwanami A; Honda H
    Schizophr Res; 1996 May; 20(1-2):241-4. PubMed ID: 8794517
    [No Abstract]   [Full Text] [Related]  

  • 16. Parallel variation of homovanillic acid and 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid of man.
    Inagawa T; Mori S; Yoshimoto H; Ishikawa S; Uozumi T
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):79-87. PubMed ID: 1026667
    [No Abstract]   [Full Text] [Related]  

  • 17. Diurnal patterns of serotonin, 5-hydroxyindoleacetic acid, tryptophan and fibrinolytic activity in blood of depressive patients and healthy volunteers.
    Pietraszek MH; Takahashi S; Takada Y; Ohara K; Inatomi H; Kondo N; Ohara K; Takada A
    Thromb Res; 1991 Oct; 64(2):243-52. PubMed ID: 1725834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid].
    Carrieri P; Orefice G; Mandarini A; Rossi V; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():42-7. PubMed ID: 95499
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonergic response to stress: a protective factor against abnormal dopaminergic reactivity in schizophrenia?
    Brunelin J; D'amato T; van Os J; Dalery J; Suaud-Chagny MF; Saoud M
    Eur Psychiatry; 2007 Sep; 22(6):362-4. PubMed ID: 17419010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
    Soda E; Miura I; Hoshino H; Kanno-Nozaki K; Ota T; Oguchi H; Watanabe K; Yang Q; Mashiko H; Niwa S
    Psychiatry Res; 2014 Dec; 220(1-2):639-45. PubMed ID: 25200191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.